Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra(University of Santo Tomas Hospital), Renato Guzmán, A Gallacher(Hospital Británico de Buenos Aires), Stephen Hall(Cabrini Hospital), Roger A. Levy(Hospital Universitário Pedro Ernesto), Renato Jimenez(Viña del Mar University), Edmund KM Li(Prince of Wales Hospital), Mathew Thomas(Kerala Institute of Medical Sciences), Ho‐Youn Kim(Catholic University of Korea), Manuel Gustavo Leon, C Tănăsescu(Spitalul Clinic Colentina), Е. Л. Насонов, Joung-Liang Lan(Taichung Veterans General Hospital), Lilia Pineda(Human Genome Sciences (United States)), Z. John Zhong(Human Genome Sciences (United States)), William W. Freimuth(Human Genome Sciences (United States)), Michelle Petri(Johns Hopkins University)
The Lancet
February 1, 2011
Cited by 2,033

Abstract


Related Papers

No related papers found

Powered by citation graph analysis